A Massachusetts-based biotech says two pharmaceutical giants are trampling its intellectual property. Factor Bioscience Inc.

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has been known to scientists and the public. There has been some progress ...

Scientists have conducted breakthrough research that could lead to a universal cancer vaccine, revolutionizing how the ...

Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on ...

DURING THE covid-19 pandemic new vaccines were rolled out with unprecedented speed. The fastest to arrive were jabs built from molecules of messenger RNA (mRNA) designed to teach the body how to fight ...

It offers a safer way to combat life-threatening cancers by teaching the body how to identify and eliminate cancer cells.

Last month, the Department of Health and Human Services (HHS) cancelled $500 million in funding for mRNA vaccine research and ...

A vaccine that uses lipid nanoparticles to deliver allergen-specific messenger RNA (mRNA) showed early positive results at managing severe allergies in tests involving mice, according to a study led ...

Former New York City Mayor Michael Bloomberg writes that the legacy of historic production of COVID vaccines in President Trump’s first term is being ruined in his second.

A group of interdisciplinary Boston University researchers worked together to investigate the promising technology of self-amplifying RNA as a way to deliver lifesaving drugs and create more effective ...